search icon
gri-img

GRI Bio Inc. Share Price

GRI
NAQ
$0.24
+$0.02
(8.99%)
1D
Industry: Biotechnology Sector: Health Care

GRI Bio Inc. Analyst Forecast

GRI Bio Inc. Share Price Chart

GRI Bio Inc. Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.25M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0.0186
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.81M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-1.44
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.19 L
$12.58 H
$0.24

About GRI Bio Inc., Common Stock

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California. more

Industry: BiotechnologySector: Health Care

GRI Bio Inc. Stock Returns

Time FrameGRISectorS&P500
1-Week Return-1.11%-1%-0.35%
1-Month Return-53.55%1.08%1.9%
3-Month Return-88.59%9.43%4.73%
6-Month Return-89.25%16.01%10.87%
1-Year Return-98.14%10.35%16.88%
3-Year Return-100%15.52%73.95%
5-Year Return-100%32.15%82.73%

GRI Bio Inc. Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue100.00K--21.77M22.54M[{"date":"2020-12-31","value":0.44,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":96.58,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue100.00K73.00K50.00K57.00K4.00K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":73,"profit":true},{"date":"2022-12-31","value":50,"profit":true},{"date":"2023-12-31","value":57,"profit":true},{"date":"2024-12-31","value":4,"profit":true}]
Gross Profit100.00K(73.00K)(50.00K)(57.00K)(4.00K)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-73,"profit":false},{"date":"2022-12-31","value":-50,"profit":false},{"date":"2023-12-31","value":-57,"profit":false},{"date":"2024-12-31","value":-4,"profit":false}]
Gross Margin100.00%--(0.26%)(0.02%)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-0.26,"profit":false},{"date":"2024-12-31","value":-0.02,"profit":false}]
Operating Expenses1.46M9.19M2.19M11.33M8.23M[{"date":"2020-12-31","value":12.88,"profit":true},{"date":"2021-12-31","value":81.08,"profit":true},{"date":"2022-12-31","value":19.32,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":72.65,"profit":true}]
Operating Income(1.46M)(9.26M)(2.24M)(11.39M)(8.23M)[{"date":"2020-12-31","value":-145900000,"profit":false},{"date":"2021-12-31","value":-925900000,"profit":false},{"date":"2022-12-31","value":-223900000,"profit":false},{"date":"2023-12-31","value":-1138700000,"profit":false},{"date":"2024-12-31","value":-823499900,"profit":false}]
Total Non-Operating Income/Expense-(591.00K)(1.63M)(4.02M)53.00K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1115.12,"profit":false},{"date":"2022-12-31","value":-3077.42,"profit":false},{"date":"2023-12-31","value":-7577.5,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(2.53M)(9.30M)(3.22M)(13.04M)(8.21M)[{"date":"2020-12-31","value":-253100000,"profit":false},{"date":"2021-12-31","value":-930300000,"profit":false},{"date":"2022-12-31","value":-321700000,"profit":false},{"date":"2023-12-31","value":-1303700000,"profit":false},{"date":"2024-12-31","value":-820700000,"profit":false}]
Income Taxes(131.30K)(50.00K)325.00K2.77M-[{"date":"2020-12-31","value":-4.75,"profit":false},{"date":"2021-12-31","value":-1.81,"profit":false},{"date":"2022-12-31","value":11.75,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes-(9.25M)(3.54M)(15.80M)-[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-925300000,"profit":false},{"date":"2022-12-31","value":-354200000,"profit":false},{"date":"2023-12-31","value":-1580200000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations-(1.56M)(3.22M)(13.30M)(8.21M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-155900000,"profit":false},{"date":"2022-12-31","value":-321700000,"profit":false},{"date":"2023-12-31","value":-1330200000,"profit":false},{"date":"2024-12-31","value":-820700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(2.53M)(9.30M)(3.22M)(13.04M)(8.21M)[{"date":"2020-12-31","value":-253100000,"profit":false},{"date":"2021-12-31","value":-930300000,"profit":false},{"date":"2022-12-31","value":-321700000,"profit":false},{"date":"2023-12-31","value":-1303700000,"profit":false},{"date":"2024-12-31","value":-820700000,"profit":false}]
EPS (Diluted)(0.33)(1.20)(0.63)(4.33K)(26.75)[{"date":"2020-12-31","value":-33,"profit":false},{"date":"2021-12-31","value":-120,"profit":false},{"date":"2022-12-31","value":-63,"profit":false},{"date":"2023-12-31","value":-432532.59,"profit":false},{"date":"2024-12-31","value":-2675.26,"profit":false}]

GRI Bio Inc. Ratios

GRI Bio Inc. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

GRI
Cash Ratio 1.47
Current Ratio 1.70

GRI Bio Inc. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

GRI
ROA (LTM) -98.68%
ROE (LTM) -248.92%

GRI Bio Inc. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

GRI
Debt Ratio Lower is generally better. Negative is bad. 0.58
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.42

GRI Bio Inc. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

GRI
Trailing PE 0.02
Forward PE NM
P/S (TTM) 0.00
P/B 1.13
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is GRI Bio Inc. share price today?

GRI Bio Inc. (GRI) share price today is $0.24

Can Indians buy GRI Bio Inc. shares?

Yes, Indians can buy shares of GRI Bio Inc. (GRI) on Vested. To buy from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GRI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of GRI Bio Inc. be purchased?

Yes, you can purchase fractional shares of GRI Bio Inc. (GRI) via the Vested app. You can start investing in GRI Bio Inc. (GRI) with a minimum investment of $1.

How to invest in GRI Bio Inc. shares from India?

You can invest in shares of GRI Bio Inc. (GRI) via Vested in three simple steps:

  • Click on Sign Up or Invest in GRI stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in GRI Bio Inc. shares
What is GRI Bio Inc. 52-week high and low stock price?

The 52-week high price of GRI Bio Inc. (GRI) is $12.58. The 52-week low price of GRI Bio Inc. (GRI) is $0.19.

What is GRI Bio Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of GRI Bio Inc. (GRI) is 0.0186

What is GRI Bio Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of GRI Bio Inc. (GRI) is 1.13

What is GRI Bio Inc. dividend yield?

The dividend yield of GRI Bio Inc. (GRI) is 0.00%

What is the Market Cap of GRI Bio Inc.?

The market capitalization of GRI Bio Inc. (GRI) is $2.25M

What is GRI Bio Inc.'s stock symbol?

The stock symbol (or ticker) of GRI Bio Inc. is GRI

How Can Investors Use GRI Bio Inc. Share Price Data for Long-Term Investment Decisions?

Consider the share price of GRI Bio Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether GRI Bio Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from GRI Bio Inc. shares for Indian investors?

When investing in GRI Bio Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the GRI Bio Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare GRI Bio Inc. share price with other stocks in the same sector?

Rather than merely checking the share price of GRI Bio Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that GRI Bio Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top